These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15715683)

  • 1. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.
    Böhm F; Beltran E; Pernow J
    J Intern Med; 2005 Mar; 257(3):263-71. PubMed ID: 15715683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
    Böhm F; Ahlborg G; Pernow J
    Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
    Rafnsson A; Shemyakin A; Pernow J
    Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.
    Cardillo C; Campia U; Kilcoyne CM; Bryant MB; Panza JA
    Circulation; 2002 Jan; 105(4):452-6. PubMed ID: 11815427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
    Shemyakin A; Böhm F; Wagner H; Efendic S; Båvenholm P; Pernow J
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):385-90. PubMed ID: 16633080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis.
    Böhm F; Ahlborg G; Johansson BL; Hansson LO; Pernow J
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):674-9. PubMed ID: 11950709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
    Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
    Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.
    Böhm F; Jensen J; Svane B; Settergren M; Pernow J
    Can J Physiol Pharmacol; 2008 Nov; 86(11):745-51. PubMed ID: 19011669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
    Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ
    Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism.
    Goddard J; Eckhart C; Johnston NR; Cumming AD; Rankin AJ; Webb DJ
    J Am Soc Nephrol; 2004 Oct; 15(10):2601-10. PubMed ID: 15466264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin blockade potentiates endothelial protective effects of ACE inhibitors in saphenous veins.
    Ko L; Maitland A; Fedak PW; Dumont AS; Badiwala M; Lovren F; Triggle CR; Anderson TJ; Rao V; Verma S
    Ann Thorac Surg; 2002 Apr; 73(4):1185-8. PubMed ID: 11996261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
    Oechslin E; Kiowski W; Schindler R; Bernheim A; Julius B; Brunner-La Rocca HP
    Circulation; 2005 Aug; 112(8):1106-12. PubMed ID: 16103236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.
    Böhm F; Settergren M; Gonon AT; Pernow J
    Clin Sci (Lond); 2005 Apr; 108(4):357-63. PubMed ID: 15610070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
    Virdis A; Ghiadoni L; Qasem AA; Lorenzini G; Duranti E; Cartoni G; Bruno RM; Bernini G; Taddei S
    Eur Heart J; 2012 Jun; 33(12):1530-8. PubMed ID: 22450428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of different antihypertensive drugs on endothelium-dependent vasodilation in the human forearm.
    Millgård J; Lind L
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):406-12. PubMed ID: 9733354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
    Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
    Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired fasting blood glucose is associated with increased endothelin-1 vasoconstrictor tone.
    Diehl KJ; Templeton DL; Ma J; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
    Atherosclerosis; 2013 Jul; 229(1):130-3. PubMed ID: 23643051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma.
    Henry E; Newby DE; Webb DJ; Hadoke PW; O'Brien CJ
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2528-32. PubMed ID: 16723466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.